LivaNova PLC (LIVN) Stock
Healthcare · Medical Devices · Member of Other US Stocks
LivaNova PLC (LIVN) closed at USD 76.08 on 2026-10-14, a change of +41.3 % over the past year, with a market capitalization of USD 4.32B.
LivaNova PLC recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 76.08 |
| 2026-10-13 | 76.37 |
| 2026-10-12 | 77.27 |
| 2026-10-09 | 76.39 |
| 2026-10-08 | 75.91 |
| 2026-10-07 | 75.93 |
| 2026-10-06 | 74.93 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
LivaNova PLC key figures
- Previous close
- USD 76.08 (2026-10-14)
- 1-year change
- +41.3 %
- Market cap
- USD 4.32B
- Enterprise value
- USD 4.16B
- P/E ratio (trailing)
- 22.62
- P/E ratio (forward)
- 16.76
- EPS (trailing)
- 3.47
- EPS (forward)
- 4.68
- PEG ratio
- 0.93
- Price to book
- 3.26
- Revenue growth
- 10.8 %
- Earnings growth
- 287.8 %
- Dividend per share (trailing)
- 0.00
- Short ratio
- 9.07
- Employees
- 3,300
- Analyst consensus (third-party)
- buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for LivaNova PLC and compare it with other stocks.
Analyze LIVNAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell LivaNova PLC shares.